Author

A. Lagana

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:clustering· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Research Focus:protein structure prediction· 2 Approach:statistical model· 2 Approach:benchmark study· 1

Frequent Co-Authors

A. Chari· 1 shared C. M. Croce· 1 shared D. Madduri· 1 shared D. T. Melnekoff· 1 shared G. L. R. Vinciguerra· 1 shared G. Nigita· 1 shared G. P. Marceca· 1 shared H. J. Cho· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Chari

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A concurrent canonical and modified miRNAome pan-cancer study on TCGA and TARGET cohorts leads to an enhanced resolution in cancer

R. Distefano, L. Tomasello, G. L. R. Vinciguerra, P. Gasparini, Y. Xiang, M. Bagnoli, G. P. Marceca, P. Fadda, A. Lagana, M. Acunzo, Q. Ma, G. Nigita, C. M. Croce

The paper analyzes miRNA modifications in cancer using TCGA and TARGET datasets, showing improved clustering and prognostic insights from combining canonical and modified miRNAs.

bioRxiv · May 18, 2021 · PreprintCancer Biology

Patient Similarity Network of Multiple Myeloma Identifies Patient Sub-groups with Distinct Genetic and Clinical Features

S. Bhalla, D. T. Melnekoff, J. Keats, K. Onel, D. Madduri, J. Richter, S. Richard, A. Chari, H. J. Cho, J. T. Dudley, S. Jagannath, A. Lagana, S. Parekh

The paper introduces MM-PSN, a multi-omics patient similarity network for Multiple Myeloma, identifying three broad groups and twelve sub-groups with distinct genetic and clinical features.

bioRxiv · Jun 2, 2020 · PreprintCancer Biology